We were excited to showcase our first scientific poster at the 13th European Meeting on Molecular Diagnostics (EMMD) in Noordwijk, an event known for bringing together top experts and innovators in the molecular diagnostics field. EMMD provides an excellent platform for Rapidemic to present our latest advancements to a community dedicated to improving diagnostic accuracy and accessibility—a perfect fit for our mission.

Violette Defourt shared her insights into our novel, single-visit point-of-care multiplex diagnostic test for Chlamydia trachomatis and Neisseria gonorrhoeae, sparking engaging discussions on its potential impact in clinical settings.

Thank you to everyone who joined us to learn more about our technology! For further details on how we’re advancing rapid diagnostics, visit our Technology Page.